National Health Investors (NYSE:NHI) Announces FY 2026 Earnings Guidance

National Health Investors (NYSE:NHI – Get Free Report) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share guidance of 4.680-4.700 for the period, compared to the consensus estimate of 4.760.

National Health Investors Price Performance

Shares of NHI opened at $71.49 on Tuesday. National Health Investors has a 52-week low of $63.51 and a 52-week high of $91.38. The company has a debt-to-equity ratio of 0.81, a quick ratio of 6.78 and a current ratio of 6.78. The firm has a market capitalization of $3.51 billion, a PE ratio of 20.66, a P/E/G ratio of 4.54 and a beta of 0.51. The stock has a 50 day simple moving average of $67.80 and a 200 day simple moving average of $76.13.

National Health Investors (NYSE:NHI – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The real estate investment trust reported $11.47 earnings per share for the quarter, topping the consensus estimate of $1.18 by $10.29. National Health Investors had a net margin of 38.56% and a return on equity of 10.89%. The company had revenue of $113.48 million for the quarter, compared to analysts’ expectations of $68.53 million. Sell-side analysts predict that National Health Investors will post 4.76 EPS for the current fiscal year.

National Health Investors Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 31st will be given a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a dividend yield of 5.1%. The ex-dividend date is Thursday, December 31st. National Health Investors’s payout ratio is currently 108.67%.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on NHI. National Bank Financial set a $79.00 price objective on shares of National Health Investors in a report on Wednesday, September 9th. Wells Fargo & Company decreased their target price on shares of National Health Investors from $78.00 to $68.00 and set an “equal weight” rating on the stock in a research report on Monday, October 19th. Truist Financial cut their target price on National Health Investors from $81.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, September 2nd. BMO Capital Markets reiterated an “outperform” rating on shares of National Health Investors in a research note on Wednesday, September 23rd. Finally, Weiss Ratings lowered shares of National Health Investors from a “buy (b-)” rating to a “hold (c+)” rating in a report on Friday, September 25th. Five investment analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $81.00.

Get Our Latest Stock Report on National Health Investors

Trending Headlines about National Health Investors

Here are the key news stories impacting National Health Investors this week:

  • Positive Sentiment: NHI reported third-quarter EPS of $11.47 and revenue of $113.5 million, above consensus estimates of $1.18 and $68.5 million, respectively. The unusually large EPS beat contrasts with the weaker FFO result below. NHI Announces Third Quarter 2026 Results
  • Positive Sentiment: The REIT declared a quarterly dividend of $0.92 per share, equivalent to $3.68 annually and a reported yield of 5.1%. One separate headline cited $0.94, so reports differ on the amount. National Health Investors declares dividend
  • Negative Sentiment: FY 2026 EPS guidance is $4.68–$4.70, below the $4.76 analyst consensus, signaling a slightly weaker outlook than expected. 2026 earnings guidance
  • Negative Sentiment: Quarterly FFO was $1.12 per share, missing the $1.17 consensus and down from $1.32 a year earlier. FFO is an important operating measure for REITs, tempering the strong reported EPS and revenue figures. NHI misses Q3 FFO estimates

About National Health Investors

(Get Free Report)

National Health Investors, Inc (NYSE: NHI) is a real estate investment trust that owns and finances properties used for senior housing and health care. Founded in 1991, the company is headquartered in Murfreesboro, Tennessee.

NHI’s portfolio includes senior housing communities, such as independent living, assisted living and memory care properties, as well as skilled nursing facilities. It typically works with health care operators through property leases and mortgage loans.

The company serves markets across the United States.

Read More

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.